DD

Dev Dutt Bablani

Director Director DIN 00422897
DIN 00422897 First appointment Oct 2004 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2004
Shareholding value Locked Premium profile

About Dev Dutt Bablani

Data last updated:

Dev Dutt Bablani has 21 years in corporate governance. Formerly with 1 company, such as Aryave Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 00422897
Primary Designation Director
First Appointment 15 Oct 2004
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Aryave Biotech Private Limited U01122DL2004PTC129990
Director15 Oct 20042004Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aryave Biotech Private Limited
Premium access

Shareholding and investment profile for Dev Dutt Bablani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dev Dutt Bablani

Dev Dutt Bablani has 21 years in corporate governance. Formerly with 1 company, such as Aryave Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Dev Dutt Bablani is associated with 0 companies as a director.

Dev Dutt Bablani has expertise in Technology.

Dev Dutt Bablani has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available